Preclinical Services
The Division of Microbiology and Infectious Diseases (DMID) has built a comprehensive set of preclinical services to facilitate efforts to develop the next generation of vaccines, diagnostics and therapeutics for a broad array of bacterial, viral, fungal and parasitic pathogens, as well as novel control approaches for invertebrate vectors of public health importance. Through these in-kind services, eligible investigators worldwide get access to expertise, research materials, and state-of-the-art technologies at minimal or no charge.
Preclinical services for product development
Clinical Services
DMID conducts and supports research to find new and improved ways to diagnose, treat and prevent virtually all human infectious diseases except HIV. In addition to grant support provided for investigator-initiated clinical trials, DMID supports clinical trials through the Infectious Diseases Clinical Research Consortium clinical trials network, the Early-Phase Clinical Trial Units, and pathogen-specific clinical trial networks such as the Antibacterial Resistance Leadership Group (ARLG) that focus on specific subsets of microbial pathogens. Consultation with relevant DMID staff is strongly encouraged to help investigators identify the best mechanism to fit their clinical trial needs.
Clinical services for product development
Contact Your Program Officer To Discuss Scientific Services
Contact DMID staff for more information about scientific services.